Only minimal information on the general performance of NTS is provided by the producer, notably with regards to their cross-reactivity with unique nitazene analogues.Cayman is a frontrunner in the sphere of emerging medicine of abuse, providing high-purity Agenda I-V Managed Substances to federally-accredited laboratories and capable academic inves